| (Values in U.S. Thousands) | Jun, 2016 | Mar, 2016 | Dec, 2015 | Sep, 2015 | Jun, 2015 |
| Sales | -9,999,000 | 3,040 | 4,000 | 3,180 | 3,090 |
| Sales Growth | -329,014.47% | -24.00% | +25.79% | +2.91% | -46.63% |
| Net Income | -9,999,000 | -9,670 | -11,540 | -10,230 | -12,510 |
| Net Income Growth | -103,302.28% | +16.20% | -12.81% | +18.23% | -4.86% |
Hansen Medical Inc (HNSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
HANSEN MEDICAL, INC., develops products & technology using robotics for the accurate positioning, manipulation and control of catheters & catheter-based technologies. Its first product, the Sensei Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately & with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map & patient electrocardiogram data & was cleared by the U.S. Food & Drug Administration in May 2007 for manipulation & control of certain mapping catheters in Electrophysiology procedures. The safety & effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including AF, have not been established. In the European Union, the Sensei system is cleared for use during EP procedures, such as guiding catheters in the treatment of atrial fibrillation.
Fiscal Year End Date: 12/31